Maryland firm announced birth of rhFVII transgenic rabbits at Chinese subsidiary. Pharming inked a service agreement with Renova Life through which the latter will develop founder transgenic rabbits ...
2d
Pharming Group Touts 2025 Sales Surge, Joenja Expansion Plans at Oppenheimer Healthcare Conference
Pharming Group (NASDAQ:PHAR) executives outlined commercial performance, pipeline priorities, and regulatory updates during a ...
Pharming uses living organisms as bioreactors for cheaper, sustainable drug production, but requires navigating complex IP and regulatory landscapes.
LONDON, July 13 (Reuters) - Dutch biotechnology company Pharming has won a green light for its drugmaking facilities, boosting prospects for the group's rabbit milk-derived drug Rhucin, its most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results